EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A mini review on drugs toxicity and antidots

Zainab Laeeq, Jaweria Naz Muqadas

Forensic Insights and Health Sciences Bulletin · 2024

DOI: 10.56770/fi2024213 ↗
AbstractBibliografische Angaben

Abstract

Drug Toxicity and Antidotes: A Comprehensive Review Drug toxicity is a significant concern in the field of medicine, as it can lead to adverse effects and potentially life-threatening situations. This review provides a comprehensive overview of drug toxicity mechanisms, risk factors, and manifestations in various organ systems. Additionally, the role of antidotes in managing drug toxicity is explored, focusing on their mechanisms of action and limitations. The potential future directions in antidote development, including personalized medicine and nanotechnology, are also discussed. Understanding drug toxicity and the available antidotes is crucial for healthcare professionals to provide effective treatment and improve patient outcomes. Pharmacogenomics and Personalized Antidote Selection for Drug Toxicity Management Pharmacogenomics has emerged as a powerful tool in predicting individual responses to medications. In the context of drug toxicity management, this review examines how genetic variations in drug metabolism enzymes and drug receptors can influence drug toxicity susceptibility. By utilizing pharmacogenomic information, healthcare providers can tailor antidote selection to individual patients, enhancing treatment efficacy while minimizing adverse reactions. The potential implications of personalized antidotes in improving patient care and safety are discussed, highlighting the importance of incorporating pharmacogenomics into clinical practice. Nanotechnology-Based Antidotes for Drug Toxicity: A Promising Approach Nanotechnology offers a novel avenue for developing targeted antidotes for drug toxicity. This article discusses recent advancements in nanotechnology and its applications in drug delivery and antidote administration. Nanoengineered particles can enhance the selectivity and effectiveness of antidotes by delivering them directly to affected tissues or organs. The potential benefits of nanotechnology-based antidotes, such as reduced systemic toxicity and improved therapeutic outcomes, are explored.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →